Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SNN - SMITH & NEPHEW PLC


Close
30.69
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:00:22 PM CET
Surgical and Medical Instrument Manufacturing : 0.39%

PREVIOUS CLOSE
CHG
CHG%

$30.69
-5.88
0.24%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-2.61%
1 Month
-1.52%
3 Months
-19.57%
6 Months
-2.61%
1 Year
-8.80%
2 Year
-7.61%
Key data
Stock price
$30.69
P/E Ratio 
51.28
DAY RANGE
$24.81 - $30.69
EPS 
$0.60
52 WEEK RANGE
$23.99 - $31.72
52 WEEK CHANGE
-$9.60
MARKET CAP 
13.487 B
YIELD 
2.41%
SHARES OUTSTANDING 
437.175 M
DIVIDEND
$0.288
EX-DIVIDEND DATE
04/01/2024
NEXT EARNINGS DATE
N/A
BETA 
0.72
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$892,901
AVERAGE 30 VOLUME 
$736,700
Company detail
CEO: Deepak S. Nath
Region: US
Website: smith-nephew.com
Employees: 20,100
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Smith & Nephew plc develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products. It also provides sports medicine joint repair products for surgeons.

Recent news